GlassScriptPhysician profile
Eric M Lindvall
NPI 1124025325
$609,336.70
in general payments reported to CMS, 2019-2025
9 companies · $100K in 2025
The $100K reported for 2025 was more than what 95% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153K · 2020: $39K · 2021: $68K · 2022: $86K · 2023: $89K · 2024: $75K · 2025: $100K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $240K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $1,416 · Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $240,171.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,400.00 |
| Travel and Lodging | $1,415.50 |
| Food and Beverage | $1,359.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Central California Surgical Distributors, LLC | $581,549.00 | 2019-2025 | |
| Smith+Nephew, INC. | $22,777.10 | 2019-2025 | Evos, Trigen Intertan, Trigen |
| Renovis Surgical Technologies, INC. | $2,801.64 | 2019 | |
| Kyocera Medical Technologies, INC. | $1,623.03 | 2020-2022 | |
| Depuy Synthes Sales INC. | $304.66 | 2022-2024 | Na, Motoband |
| Stryker Corporation | $129.57 | 2023-2025 | Axsos, Pangea, Gamma |
| Axogen | $120.00 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Vertex Pharmaceuticals Incorporated | $17.57 | 2024 | |
| Sanara Medtech INC. | $14.13 | 2024 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$548,671.92 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lindvall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.